Prognostic significance of KRAS mutation rate in metastatic colorectal cancer patients

被引：0
|
作者：
Vincenzi, B. [1 ]
Cremolini, C. [2 ]
Sartore-Bianchi, A. [3 ]
Russo, A. [4 ]
Mannavola, F. [5 ]
Perrone, G. [6 ]
Pantano, F. [1 ]
Loupakis, F. [2 ]
Rossini, D. [2 ]
Ongaro, E. [7 ]
Bonazzina, E. [3 ]
Zoccoli, A. [1 ]
De Maglio, G. [7 ]
Fontanini, G. [8 ]
Falcone, A. [2 ]
Santini, D. [1 ]
Onetti-Muda, A. [6 ]
Siena, S. [3 ]
Tonini, G. [1 ]
Aprile, G. [7 ]
机构：
[1] Campus Biomed Univ Rome, Dept Med Oncol, Rome, Italy
[2] Azienda Osped Univ Pisana, Ist Toscano Tumori, Pisa, Italy
[3] Osped Niguarda Ca Granda, Niguarda Canc Ctr, Milan, Italy
[4] AOUP, Dept Oncol, Unit Med Oncol, Palermo, Italy
[5] Univ Cattolica Sacro Cuore, Rome, Italy
[6] Campus Biomed Univ Rome, Dept Anat Pathol, Rome, Italy
[7] Azienda Osped Univ, Dept Med Oncol, Udine, Italy
[8] Univ Pisa, Dipartimento Patol Chirurg Med Mol & Area Crit, Pisa, Italy
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
E08
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [1] Prognostic significance of KRAS mutation rate in metastatic colorectal cancer (mCRC) patients (pts).
    Vincenzi, Bruno
    Loupakis, Fotios
    Bianchi, Andrea Sartore
    Russo, Antonio
    Mannavola, Francesco
    Perrone, Giuseppe
    Cremolini, Chiara
    Rossini, Daniele
    Ongaro, Elena
    Bonazzina, Erica
    Dell'Aquila, Emanuela
    Imperatori, Marco
    De Maglio, Giovanna
    Falcone, Alfredo
    Santini, Daniele
    Onetti-Muda, Andrea
    Siena, Salvatore
    Aprile, Giuseppe
    Tonini, Giuseppe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] Prognostic significance of K-Ras mutation rate in metastatic colorectal cancer patients
    Vincenzi, Bruno
    Cremolini, Chiara
    Sartore-Bianchi, Andrea
    Russo, Antonio
    Mannavola, Francesco
    Perrone, Giuseppe
    Pantano, Francesco
    Loupakis, Fotios
    Rossini, Daniele
    Ongaro, Elena
    Bonazzina, Erica
    Dell'Aquila, Emanuela
    Imperatori, Marco
    Zoccoli, Alice
    Bronte, Giuseppe
    De Maglio, Giovanna
    Fontanini, Gabriella
    Natoli, Clara
    Falcone, Alfredo
    Santini, Daniele
    Onetti-Muda, Andrea
    Siena, Salvatore
    Tonini, Giuseppe
    Aprile, Giuseppe
    [J]. ONCOTARGET, 2015, 6 (31) : 31604 - 31612
  • [3] The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
    Daeyoun David Won
    Jae Im Lee
    In Kyu Lee
    Seong-Taek Oh
    Eun Sun Jung
    Sung Hak Lee
    [J]. BMC Cancer, 17
  • [4] The prognostic significance of KRAS and BRAF mutation status in Korean colorectal cancer patients
    Won, Daeyoun David
    Lee, Jae Im
    Lee, In Kyu
    Oh, Seong-Taek
    Jung, Eun Sun
    Lee, Sung Hak
    [J]. BMC CANCER, 2017, 17
  • [5] Influence of KRAS mutation on prognostic impact of systemic inflammation in metastatic colorectal cancer patients
    Miyamoto, Yuji
    Hiyoshi, Yukiharu
    Daitoku, Nobuya
    Sakamoto, Yuki
    Kiyozumi, Yuki
    Eto, Kojiro
    Iwagami, Shiro
    Iwatsuki, Masaaki
    Baba, Yoshifumi
    Yoshida, Naoya
    Baba, Hideo
    [J]. CANCER SCIENCE, 2018, 109 : 1357 - 1357
  • [6] Prognostic and predictive value of KRAS mutation number in metastatic colorectal cancer
    Ucar, Gokhan
    Ergun, Yakup
    Esen, Selin Akturk
    Acikgoz, Yusuf
    Dirikoc, Merve
    Esen, Irfan
    Bal, Oznur
    Uncu, Dogan
    [J]. MEDICINE, 2020, 99 (39) : E22407
  • [7] The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
    Huang, Ching-Wen
    Tsai, Hsiang-Lin
    Chen, Yi-Ting
    Huang, Chun-Ming
    Ma, Cheng-Jen
    Lu, Chien-Yu
    Kuo, Chao-Hung
    Wu, Deng-Chyang
    Chai, Chee-Yin
    Wang, Jaw-Yuan
    [J]. BMC CANCER, 2013, 13
  • [8] The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer
    Ching-Wen Huang
    Hsiang-Lin Tsai
    Yi-Ting Chen
    Chun-Ming Huang
    Cheng-Jen Ma
    Chien-Yu Lu
    Chao-Hung Kuo
    Deng-Chyang Wu
    Chee-Yin Chai
    Jaw-Yuan Wang
    [J]. BMC Cancer, 13
  • [9] KRAS Mutation is a Poor Prognostic Factor in Patients undergoing Hepatic Resection for Metastatic Colorectal Cancer
    Aufforth, R. D.
    Baker, J. J.
    Auman, J.
    Eil, R.
    McLeod, H.
    Kim, H.
    Meyers, M. O.
    Calvo, B. F.
    Yeh, J.
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2012, 19 : S94 - S95
  • [10] KRAS mutation as a prognostic factor in patients undergoing hepatic resection for metastatic colorectal cancer.
    Baker, Justin John
    Aufforth, Rachel
    Auman, James Todd
    Eil, Robert
    McLeod, Howard L.
    Kim, Hong Jin
    Meyers, Michael O.
    Calvo, Benjamin F.
    Yeh, Jen Jen
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
12345